Laurel Beckett
#78,245
Most Influential Person Now
American biostatistician
Laurel Beckett's AcademicInfluence.com Rankings
Laurel Beckettmathematics Degrees
Mathematics
#6298
World Rank
#8750
Historical Rank
Statistics
#625
World Rank
#708
Historical Rank
Download Badge
Mathematics
Laurel Beckett's Degrees
- PhD Biostatistics University of California, Berkeley
- Masters Biostatistics University of California, Berkeley
- Bachelors Statistics University of California, Davis
Why Is Laurel Beckett Influential?
(Suggest an Edit or Addition)According to Wikipedia, Laurel Alison Beckett is an American biostatistician specializing in Alzheimer's disease and other age-related causes of cognitive impairment. Beyond biostatistics, she has also worked as an activist for women in medicine, including the advocacy of flexible career options allowing women to balance medical careers with childrearing. She is retired as distinguished professor emerita from the UC Davis School of Medicine, where she was chief of biostatistics and directed the biostatistics core of the Alzheimer's Disease Neuroimaging Initiative.
Laurel Beckett's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease (2011) (5616)
- The Alzheimer's disease neuroimaging initiative. (2005) (3069)
- Alzheimer's Disease Neuroimaging Initiative (2008) (1024)
- Ways toward an early diagnosis in Alzheimer’s disease: The Alzheimer’s Disease Neuroimaging Initiative (ADNI) (2005) (970)
- Natural history of mild cognitive impairment in older persons (2002) (907)
- Individual differences in rates of change in cognitive abilities of older persons. (2002) (780)
- Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis (2016) (716)
- Alzheimer's Disease Neuroimaging Initiative (ADNI) (2010) (712)
- Prevalence of parkinsonian signs and associated mortality in a community population of older people. (1996) (661)
- Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment (2002) (638)
- Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup (2011) (624)
- The Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception (2012) (553)
- The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception (2012) (513)
- Age-specific incidence of Alzheimer's disease in a community population. (1995) (486)
- MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer’s disease☆ ☆ This research was supported by grants P01 AG09466 and P30 AG10161 from the National Institute on Aging, National Institutes of Health. (2001) (483)
- Depressive symptoms, cognitive decline, and risk of AD in older persons (2002) (480)
- The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans (2010) (473)
- Annual Incidence of Alzheimer Disease in the United States Projected to the Years 2000 Through 2050 (2001) (452)
- Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older persons. (1997) (435)
- Clinical core of the Alzheimer's disease neuroimaging initiative: Progress and plans (2010) (395)
- Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status. (2003) (336)
- Vitamin E and Vitamin C Supplement Use and Risk of Incident Alzheimer Disease (1998) (327)
- Level of education and change in cognitive function in a community population of older persons. (1993) (314)
- Analysis of change in self-reported physical function among older persons in four population studies. (1996) (304)
- Longitudinal volumetric MRI change and rate of cognitive decline (2005) (299)
- A lack of default network suppression is linked to increased distractibility in ADHD (2009) (293)
- 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception (2015) (287)
- Acute delirium and functional decline in the hospitalized elderly patient. (1993) (286)
- Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates. The RV-43 Study Group, the AIDS Clinical Trials Group Virology Committee Resistance Working Group (1993) (281)
- Is the risk of developing Alzheimer's disease greater for women than for men? (2001) (275)
- Current and remote blood pressure and cognitive decline. (1999) (271)
- Social networks and disability transitions across eight intervals of yearly data in the New Haven EPESE. (1999) (263)
- Incidence, mechanism and prognostic value of activated AKT in pancreas cancer (2003) (262)
- Longitudinal MRI atrophy biomarkers: Relationship to conversion in the ADNI cohort (2010) (250)
- Morbidity, mortality, and technical factors of distal pancreatectomy. (2002) (228)
- Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative (2018) (225)
- Validation of a meta-analysis: the effects of fish oil in rheumatoid arthritis. (1995) (224)
- Entorhinal Cortex β-Amyloid Load in Individuals with Mild Cognitive Impairment (1999) (222)
- Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative. (2010) (221)
- Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials (2017) (214)
- The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement (2017) (206)
- The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. (2002) (203)
- Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older persons. (1997) (201)
- Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer's pathology (2016) (201)
- Four distinct trajectories of tau deposition identified in Alzheimer’s disease (2021) (200)
- Cognitive activity in older persons from a geographically defined population. (1999) (198)
- Measuring cognitive reserve based on the decomposition of episodic memory variance. (2010) (197)
- Correlates of Behavior Problems in Children with Epilepsy (1992) (196)
- Design of the Chicago Health and Aging Project (CHAP). (2003) (194)
- Contrast-enhanced dedicated breast CT: initial clinical experience. (2010) (184)
- White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities (2019) (182)
- Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014 (2015) (175)
- Residential proximity to naturally occurring asbestos and mesothelioma risk in California. (2005) (171)
- Vitamin D Status and Rates of Cognitive Decline in a Multiethnic Cohort of Older Adults. (2015) (165)
- Six-year effect of depressive symptoms on the course of physical disability in community-living older adults. (2000) (164)
- Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE (2015) (161)
- Terminal decline in cognitive function (2003) (158)
- Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale (1997) (151)
- Estimating long-term multivariate progression from short-term data (2014) (147)
- Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma? (2002) (144)
- Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment. (2014) (144)
- Progression of gait disorder and rigidity and risk of death in older persons (2002) (143)
- Heterogeneity of cognitive trajectories in diverse older persons. (2010) (139)
- APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern (2015) (138)
- Hallucinations, delusions, and cognitive decline in Alzheimer's disease (2000) (137)
- Predicting Alzheimer’s disease progression using multi-modal deep learning approach (2019) (136)
- Relation of smoking and alcohol consumption to incident Alzheimer's disease. (1992) (130)
- Weight loss in people with Alzheimer's disease: a prospective population based analysis (1997) (130)
- Black-white differences in risk of becoming disabled and recovering from disability in old age: a longitudinal analysis of two EPESE populations. (1997) (125)
- Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials. (2005) (124)
- Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer. (2004) (123)
- Psychotic Symptoms and Physically Aggressive Behavior in Alzheimer's Disease (1997) (123)
- Relation of smoking and low-to-moderate alcohol consumption to change in cognitive function: a longitudinal study in a defined community of older persons. (1993) (121)
- Change in cognitive function in older persons from a community population: relation to age and Alzheimer disease. (1999) (121)
- Interpretable classification of Alzheimer’s disease pathologies with a convolutional neural network pipeline (2018) (118)
- Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment. (1999) (115)
- Person-specific paths of cognitive decline in Alzheimer's disease and their relation to age. (2000) (115)
- Serial changes in blood pressure from adolescence into adulthood. (1992) (114)
- Size bias of fragile X premutation alleles in late-onset movement disorders (2006) (109)
- The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes (2010) (106)
- Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases (2012) (104)
- Comparison of neurologic changes in 'successfully aging' persons vs the total aging population. (1994) (102)
- Simultaneous care: a model approach to the perceived conflict between investigational therapy and palliative care. (2004) (101)
- Biological heterogeneity in ADNI amnestic mild cognitive impairment (2014) (98)
- Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease (2020) (96)
- MRI predictors of cognitive change in a diverse and carefully characterized elderly population (2012) (94)
- Premorbid reading activity and patterns of cognitive decline in Alzheimer disease. (2000) (94)
- Pentoxifylline decreases tumor necrosis factor expression and serum triglycerides in people with AIDS. NIAID AIDS Clinical Trials Group. (1993) (92)
- Effects of a problem-solving intervention (COPE) on quality of life for patients with advanced cancer on clinical trials and their caregivers: simultaneous care educational intervention (SCEI): linking palliation and clinical trials. (2011) (89)
- Tau‐66: evidence for a novel tau conformation in Alzheimer's disease (2001) (89)
- Dimensionality of parkinsonian signs in aging and Alzheimer's disease. (1999) (88)
- Demographic predictors of cognitive change in ethnically diverse older persons. (2013) (87)
- Acetaminophen and diphenhydramine as premedication for platelet transfusions: A prospective randomized double‐blind placebo‐controlled trial (2002) (83)
- Modern parathyroid surgery: a cost-benefit analysis of localizing strategies. (2002) (81)
- Recruitment of a Community-based Cohort for Research on Diversity and Risk of Dementia (2010) (79)
- Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's disease (2014) (77)
- Seroprevalence of antibodies against Bartonella species and evaluation of risk factors and clinical signs associated with seropositivity in dogs. (2005) (75)
- Non-coding variability at the APOE locus contributes to the Alzheimer’s risk (2019) (74)
- Functional disability among elderly blacks and whites in two diverse areas: the New Haven and North Carolina EPESE. Established Populations for the Epidemiologic Studies of the Elderly. (1995) (74)
- Effects of a mushroom mycelium extract on the treatment of prostate cancer. (2002) (73)
- Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies: Harmonization for international trials (2018) (71)
- EGFR Mutations Detected in Plasma Are Associated with Patient Outcomes in Erlotinib Plus Docetaxel-Treated Non-small Cell Lung Cancer (2009) (70)
- Overcoming barriers to cancer clinical trial accrual (2008) (69)
- Robust Identification of Alzheimer’s Disease subtypes based on cortical atrophy patterns (2017) (69)
- Career flexibility and family-friendly policies: an NIH-funded study to enhance women's careers in biomedical sciences. (2011) (69)
- Acculturation and its association with health-risk behaviors in a rural Latina population. (2005) (68)
- Brain Volume Change and Cognitive Trajectories in Aging (2018) (67)
- Large-Scale Screening and Molecular Characterization of EML4-ALK Fusion Variants in Archival Non–Small-Cell Lung Cancer Tumor Specimens Using Quantitative Reverse Transcription Polymerase Chain Reaction Assays (2014) (62)
- The Alzheimer's Disease Neuroimaging Initiative phase 2: Increasing the length, breadth, and depth of our understanding (2015) (62)
- Effect of ERCP Mechanical Simulator (EMS) Practice on Trainees’ ERCP Performance in the Early Learning Period: US Multicenter Randomized Controlled Trial (2011) (61)
- Progression from normal cognition to mild cognitive impairment in a diverse clinic-based and community-based elderly cohort (2017) (60)
- Progression of parkinsonism and loss of cognitive function in Alzheimer disease. (2000) (59)
- Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans (2012) (59)
- Subtypes based on cerebrospinal fluid and magnetic resonance imaging markers in normal elderly predict cognitive decline (2010) (59)
- Brachial plexus-associated neuropathy after high-dose radiation therapy for head-and-neck cancer. (2012) (58)
- Pulmonary function and exercise-associated changes with chronic low-level paraquat exposure. (2004) (58)
- Analysis of Genetic Algorithm for Rule-Set Production (GARP) Modeling Approach for Predicting Distributions of Fleas Implicated as Vectors of Plague, Yersinia pestis, in California (2006) (58)
- Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer’s disease (2017) (58)
- Beta amyloid, tau, neuroimaging, and cognition: sequence modeling of biomarkers for Alzheimer’s Disease (2012) (58)
- Temporal changes in characteristics of injection-site sarcomas in cats: 392 cases (1990-2006). (2009) (57)
- Serial analysis of plasma lipids and lipoproteins from individuals 9-21 y of age. (1993) (56)
- Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology (2020) (56)
- Cytokine dysregulation in AIDS: in vivo overexpression of mRNA of tumor necrosis factor-alpha and its correlation with that of the inflammatory cytokine GRO. (1992) (56)
- Population prevalence estimates from complex samples. (1992) (56)
- Ospemifene inhibits the growth of dimethylbenzanthracene-induced mammary tumors in Sencar mice (2005) (54)
- Relationships among Food Label Use, Motivation, and Dietary Quality (2015) (53)
- The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory (2019) (52)
- The Natural History of Cardiac and Pulmonary Function Decline in Patients With Duchenne Muscular Dystrophy (2011) (51)
- Maximal brain size remains an important predictor of cognition in old age, independent of current brain pathology (2012) (51)
- Midkine is a NF-κB-inducible gene that supports prostate cancer cell survival (2008) (51)
- Decline of language among women and men with Alzheimer's disease (2000) (51)
- Longitudinal trajectories of everyday function by diagnostic status. (2013) (50)
- Do behavioral disturbances in persons with Alzheimer's disease predict caregiver depression over time? (2004) (50)
- Gamma Interferon-Mediated Inflammation Is Associated with Lack of Protection from Intravaginal Simian Immunodeficiency Virus SIVmac239 Challenge in Simian-Human Immunodeficiency Virus 89.6-Immunized Rhesus Macaques (2004) (50)
- Concordance between direct observation and staff rating of behavior in nursing home residents with Alzheimer's disease. (1997) (49)
- SEASONAL HEMATOLOGY AND SERUM CHEMISTRY OF WILD BELUGA WHALES (DELPHINAPTERUS LEUCAS) IN BRISTOL BAY, ALASKA, USA (2012) (49)
- Differential response rates to irradiation among patients with human papillomavirus positive and negative oropharyngeal cancer (2013) (48)
- A randomized, placebo-controlled study of the immunogenicity of human immunodeficiency virus (HIV) rgp160 vaccine in HIV-infected subjects with > or = 400/mm3 CD4 T lymphocytes (AIDS Clinical Trials Group Protocol 137). (1996) (48)
- ZNF217, a candidate breast cancer oncogene amplified at 20q13, regulates expression of the ErbB3 receptor tyrosine kinase in breast cancer cells (2010) (47)
- Trends in colorectal cancer testing among Medicare subpopulations. (2008) (46)
- The membrane mucin MUC4 is elevated in breast tumor lymph node metastases relative to matched primary tumors and confers aggressive properties to breast cancer cells (2009) (45)
- Intermittent Erlotinib in Combination with Pemetrexed: Phase I Schedules Designed to Achieve Pharmacodynamic Separation (2009) (45)
- A phase 2 clinical trial of everolimus plus bicalutamide for castration‐resistant prostate cancer (2016) (45)
- Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts (2016) (44)
- Effects of Patient and Physician Practice Socioeconomic Status on the Health Care of Privately Insured Managed Care Patients (2003) (42)
- Neuropathological Diagnoses of Demented Hispanic, Black, and Non-Hispanic White Decedents Seen at an Alzheimer's Disease Center. (2019) (41)
- Do Family Responsibilities and a Clinical Versus Research Faculty Position Affect Satisfaction with Career and Work-Life Balance for Medical School Faculty? (2015) (40)
- Spectral Analysis for Discrete Longitudinal Data (1994) (39)
- Salzmann Nodular Degeneration (2010) (39)
- Independent Review of Interstitial Lung Disease Associated with Death in TRIBUTE (Paclitaxel and Carboplatin with or without Concurrent Erlotinib) in Advanced Non-small Cell Lung Cancer (2007) (39)
- A longitudinal study of parkinsonism and disability in a community population of older people. (2004) (38)
- Occupational paraquat exposure of agricultural workers in large Costa Rican farms (2009) (37)
- Mining Outcome-relevant Brain Imaging Genetic Associations via Three-way Sparse Canonical Correlation Analysis in Alzheimer’s Disease (2017) (36)
- Ex vivo expansion of HIV type 1-specific cytolytic T cells from HIV type 1-seropositive subjects. (1995) (36)
- Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team (2016) (35)
- Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics (2019) (35)
- Estimating Youth Locomotion Ground Reaction Forces Using an Accelerometer-Based Activity Monitor (2012) (35)
- Subgroup of ADNI normal controls characterized by atrophy and cognitive decline associated with vascular damage. (2013) (34)
- Large-scale genomics unveil polygenic architecture of human cortical surface area (2015) (34)
- Generational and gender perspectives on career flexibility: ensuring the faculty workforce of the future. (2012) (33)
- Quantitation of fixative-induced morphologic and antigenic variation in mouse and human breast cancers (2013) (33)
- Comparison of two-dimensional and three-dimensional iterative watershed segmentation methods in hepatic tumor volumetrics. (2008) (33)
- A microdosing approach for characterizing formation and repair of carboplatin–DNA monoadducts and chemoresistance (2011) (32)
- Survival analysis of dogs diagnosed with canine peritoneal larval cestodiasis (Mesocestoides spp.). (2011) (32)
- Barriers to Career Flexibility in Academic Medicine: A Qualitative Analysis of Reasons for the Underutilization of Family-Friendly Policies, and Implications for Institutional Change and Department Chair Leadership (2017) (32)
- Survival and cell cycle kinetics of human prostate cancer cell lines after single- and multifraction exposures to ionizing radiation. (2004) (32)
- Nine‐color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part II: Panel performance across different instrument platforms (2008) (31)
- An Evaluation of Barriers to Accrual in the Era of Legislation Requiring Insurance Coverage of Cancer Clinical Trial Costs in California (2004) (31)
- Serum p24 antigen level as an intermediate end point in clinical trials of zidovudine in people infected with human immunodeficiency virus type 1. Aids Clinical Trials Group Virology Laboratories. (1994) (31)
- Motility and ultrastructure of large granular lymphocytes on lipid bilayers reconstituted with adhesion receptors LFA-1, ICAM-1, and two isoforms of LFA-3 (1991) (31)
- Outcomes of comprehensive heart care programs in high-risk women. (2010) (30)
- Clinical-dosimetric relationship between lacrimal gland dose and ocular toxicity after intensity-modulated radiotherapy for sinonasal tumours. (2013) (30)
- Intercalated Erlotinib-Docetaxel Dosing Schedules Designed to Achieve Pharmacodynamic Separation: Results of a Phase I/II Trial (2011) (30)
- Algorithm for codevelopment of new drug-predictive biomarker combinations: accounting for inter- and intrapatient tumor heterogeneity. (2012) (28)
- Sex and Electrode Configuration in Transcranial Electrical Stimulation (2017) (28)
- Ethnoracial Differences in Brain Structure Change and Cognitive Change (2018) (28)
- Rigid interferon-alpha subtype responses of human plasmacytoid dendritic cells. (2008) (28)
- Genetic studies of plasma analytes identify novel potential biomarkers for several complex traits (2016) (28)
- Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy. (2007) (27)
- Impact of apolipoprotein ɛ4–cerebrospinal fluid beta-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment (2011) (27)
- Scope and Nature of Pain- and Analgesia-Related Content of the United States Medical Licensing Examination (USMLE) (2018) (27)
- The relative efficiency of time-to-threshold and rate of change in longitudinal data. (2011) (27)
- Atypical development of the executive attention network in children with chromosome 22q11.2 deletion syndrome (2010) (26)
- Women can bear a bigger burden: ante- and post-mortem evidence for reserve in the face of tau (2020) (26)
- Pharmacodynamic separation of gemcitabine and erlotinib in locally advanced or metastatic pancreatic cancer: therapeutic and biomarker results (2015) (26)
- The Effect of Hand Burns on Quality of Life in Children (2010) (26)
- Phase I Study of Two Different Schedules of Bortezomib and Pemetrexed in Advanced Solid Tumors with Emphasis on Non-small Cell Lung Cancer (2007) (25)
- Neighborhood Socioeconomic Status and Cognitive Trajectories in a Diverse Longitudinal Cohort (2018) (25)
- Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease (2021) (25)
- Reproducibility of macular thickness measurement among five OCT instruments: effects of image resolution, image registration, and eye tracking. (2012) (25)
- Characterization of MUC1 glycoprotein on prostate cancer for selection of targeting molecules. (2006) (25)
- Misunderstanding of Front-Of-Package Nutrition Information on US Food Products (2015) (24)
- Parkinsonian signs and mortality from Alzheimer's disease (1998) (23)
- Childhood blood pressure tracking correlations corrected for within-person variability. (1992) (23)
- White Matter Hyperintensities among Older Adults Are Associated with Futile Increase in Frontal Activation and Functional Connectivity during Spatial Search (2015) (23)
- Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease (2021) (22)
- Pharmacodynamic separation of erlotinib and docetaxel (DOC) in advanced non-small cell lung cancer (NSCLC): Overcoming hypothesized antagonism (2007) (22)
- BCL2 antisense reduces prostate cancer cell survival following irradiation. (2002) (22)
- An Exploration of Maitland's Concept of Pain Irritability in Patients with Low Back Pain (2009) (21)
- 18F-florbetapir Positron Emission Tomography–determined Cerebral &bgr;-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery (2018) (21)
- Skin dose effects of postmastectomy chest wall radiation therapy using brass mesh as an alternative to tissue equivalent bolus. (2013) (21)
- Novel Targeted Therapy for Precursor B-Cell Acute Lymphoblastic Leukemia: Anti-CD22 Antibody-MXD3 Antisense Oligonucleotide Conjugate (2014) (20)
- VARIATION IN HEMATOLOGIC AND SERUM BIOCHEMICAL VALUES OF BELUGAS (DELPHINAPTERUS LEUCAS) UNDER MANAGED CARE (2013) (20)
- Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer’s Disease via Fusion of Clinical, Imaging and Omic Features (2017) (20)
- Asian Americans and cancer clinical trials (2005) (20)
- The Contributions of MRI-Based Measures of Gray Matter, White Matter Hyperintensity, and White Matter Integrity to Late-Life Cognition (2012) (20)
- Headache relief after anterior cervical discectomy: post hoc analysis of a randomized investigational device exemption trial: clinical article. (2014) (20)
- KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease (2021) (19)
- The Apolipoprotein E 4 Allele and Decline in Different Cognitive Systems During a 6-Year Period (2002) (19)
- A Novel Joint Brain Network Analysis Using Longitudinal Alzheimer’s Disease Data (2019) (19)
- Temporal patterns of negative and positive behavior among nursing home residents with Alzheimer's disease. (2004) (18)
- MXD3 antisense oligonucleotide with superparamagnetic iron oxide nanoparticles: A new targeted approach for neuroblastoma. (2019) (17)
- Novel Targeted Therapy for Neuroblastoma: Silencing the MXD3 Gene Using siRNA (2014) (17)
- Potential natural and anthropogenic impediments to the conservation and recovery of cook inlet beluga whales, Delphinapterus leucas (2016) (17)
- Evaluating a Medical School's Climate for Women's Success: Outcomes for Faculty Recruitment, Retention, and Promotion. (2017) (17)
- Synaptophysin-Ki67 Double Stain: A Novel Technique That Improves Interobserver Agreement in the Grading of Well-Differentiated Gastrointestinal Neuroendocrine Tumors (2016) (17)
- The Reliability of Maitland's Irritability Judgments in Patients with Low Back Pain (2009) (17)
- ZNF 217 , a candidate breast cancer oncogene amplified at 20 q 13 , regulates expression of the ErbB 3 receptor tyrosine kinase in breast cancer cells (2014) (17)
- Age differences in the use of serving size information on food labels: numeracy or attention? (2016) (16)
- Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status (2021) (16)
- Multivariate modeling of two associated cognitive outcomes in a longitudinal study. (2003) (16)
- Improving Knowledge, Awareness, and Use of Flexible Career Policies Through an Accelerator Intervention at the University of California, Davis, School of Medicine (2013) (16)
- Genome-wide association analysis of hippocampal volume identifies enrichment of neurogenesis-related pathways (2016) (16)
- Thymidylate synthase (TS) gene expression in patients with ALK positive (+) non-small cell lung cancer (NSCLC): Implications for therapy. (2012) (15)
- White matter hyperintensities are associated with visual search behavior independent of generalized slowing in aging (2014) (15)
- Sources of priming in text rereading: intact implicit memory for new associations in older adults and in patients with Alzheimer's disease. (1997) (15)
- Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer’s Dementia (2018) (15)
- Escalating weekly doses of cetuximab and correlation with skin toxicity: A phase I study (2011) (15)
- Does early posttreatment surveillance imaging affect subsequent management following stereotactic body radiation therapy for early-stage non-small cell lung cancer? (2014) (14)
- Developing Nutrition Label Reading Skills: A Web-Based Practice Approach (2017) (14)
- Detection by immunofixation of M proteins in hypogammaglobulinemic patients with normal serum protein electrophoresis results. (2007) (14)
- Survival benefits associated with surgery for advanced non–small cell lung cancer (2019) (13)
- Antipsychotic Use in a Diverse Population With Dementia: A Retrospective Review of the National Alzheimer's Coordinating Center Database. (2015) (13)
- Interpretable classification of Alzheimer’s disease pathologies with a convolutional neural network pipeline (2019) (13)
- Nanomolecular HLA-DR10 antibody mimics: A potent system for molecular targeted therapy and imaging. (2008) (13)
- Maximum Likelihood Estimation in Mallows’s Model Using Partially Ranked Data (1993) (12)
- Ideal Worker and Academic Professional Identity: Perspectives from a Career Flexibility Educational Intervention. (2017) (12)
- Comparison of C-reactive protein and metabolic syndrome as cardiovascular risk factors in African-Americans and European-Americans. (2009) (12)
- Mediating Effect of Postsurgical Chemotherapy on Presence of Dementia and Survival among Patients 65 and Older with Stage III Colon Cancer (2017) (12)
- A Model to Predict the Use of Surgical Resection for Advanced-Stage Non-Small Cell Lung Cancer Patients. (2017) (12)
- A semi-mechanism approach based on MRI and proteomics for prediction of conversion from mild cognitive impairment to Alzheimer’s disease (2016) (12)
- Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study (2021) (12)
- Molecular specific and cell selective cytotoxicity induced by a novel synthetic HLA-DR antibody mimic for lymphoma and leukemia. (2009) (11)
- Pembrolizumab Combined With Either Docetaxel or Gemcitabine in Patients With Advanced or Metastatic Platinum‐Refractory Urothelial Cancer: Results From a Phase I Study (2018) (11)
- Combination checkpoint immunotherapy and cytotoxic chemotherapy: Pembrolizumab (Pembro) plus either docetaxel or gemcitabine in patients with advanced or metastatic urothelial cancer. (2017) (11)
- Fecal pathogen pollution: sources and patterns in water and sediment samples from the upper Cook Inlet, Alaska ecosystem. (2013) (10)
- The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI‐3 updates and global perspectives (2021) (10)
- Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancer (2013) (10)
- Community-based studies of Alzheimer's disease: statistical challenges in design and analysis. (2000) (10)
- Aging in Fragile X Premutation Carriers (2016) (10)
- A modified yeast assay used on archival samples of localized prostate cancer tissue improves the detection of p53 abnormalities and increases their predictive value (2004) (10)
- The impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuum (2016) (10)
- Designing a Randomized Phase I/II Prostate Cancer Chemoprevention Trial Using 1α‐Hydroxy‐24‐Ethyl‐Cholecalciferol, an Analogue of Vitamin D3 (2004) (9)
- Perspectives of emergency department attendees on outcomes of resuscitation efforts: origins and impact on cardiopulmonary resuscitation preference (2020) (9)
- Phase I study of INC280 plus erlotinib in patients with MET expressing adenocarcinoma of the lung. (2015) (9)
- FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease (2020) (9)
- Evaluation of California's Armed and Prohibited Persons System: study protocol for a cluster-randomised trial (2016) (9)
- Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer’s disease (2021) (9)
- Prospective Evaluation of Low-Dose Ketoconazole Plus Hydrocortisone (HC) in Docetaxel Pre-treated Castration-Resistant Prostate Cancer (CRPC) Patients (2015) (9)
- Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease (2022) (9)
- An Evaluation of an eHealth Tool Designed to Improve College Students’ Label-Reading Skills and Feelings of Empowerment to Choose Healthful Foods (2018) (8)
- Intermittent erlotinib (ERL) in combination with pemetrexed (PEM): Phase I schedules designed to achieve pharmacodynamic separation (2008) (8)
- Standardized submaximal exercise testing in never smokers: a normative study. (2001) (8)
- Phase I/II Study of Capmatinib Plus Erlotinib in Patients With MET-Positive Non–Small-Cell Lung Cancer (2021) (8)
- A telescope GWAS analysis strategy, based on SNPs-genes-pathways ensamble and on multivariate algorithms, to characterize late onset Alzheimer’s disease (2020) (8)
- Serum levels of soluble CD8, neopterin, β2‐microglobulin and p24 antigen as indicators of disease progression in children with AIDS on zidovudine therapy (1993) (7)
- Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization (2021) (7)
- A Landscape of Subjective and Objective Stress in African-American Dementia Family Caregivers (2021) (7)
- Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume (2022) (6)
- Autosomal dominant and sporadic late onset Alzheimer disease share a common in vivo pathophysiology. (2022) (6)
- On the analysis of count data of birth‐and‐death process type: with application to molecularly targeted cancer therapy (2007) (6)
- Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer’s disease (2022) (6)
- Erlotinib and vinorelbine in advanced malignant solid tumors: a phase I study (2007) (6)
- Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference (2018) (6)
- Novel p53/p130 axis in bladder tumors. (2007) (6)
- Randomized Phase 2 Trial of Pharmacodynamic Separation of Pemetrexed and Intercalated Erlotinib Versus Pemetrexed Alone for Advanced Nonsquamous, Non–small‐cell Lung Cancer (2017) (6)
- Parametric empirical Bayes estimates of disease prevalence using stratified samples from community populations. (2000) (6)
- Predicting Alzheimer’s disease progression using multi-modal deep learning approach (2019) (6)
- Attenuated Age-Impact on Systemic Inflammatory Markers in the Presence of a Metabolic Burden (2015) (6)
- Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community‐engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4 (2022) (6)
- An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer’s disease (2022) (5)
- Encouraging activity of bicalutamide and everolimus in castration-resistant prostate cancer (CRPC): Early results from a phase II clinical trial. (2010) (5)
- Longitudinal Influences of Partner Depression on Cognitive Functioning in Latino Spousal Pairs (2009) (5)
- The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory (2019) (5)
- Randomized phase II study of pharmacodynamic separation (PDS) of pemetrexed (Pem) and erlotinib (Erl) versus pem alone in patients (pts) with advanced non-small cell lung cancer (NSCLC). (2013) (5)
- Independent review of fatal interstitial lung disease (ILD) in TRIBUTE: paclitaxel + carboplatin ± erlotinib in advanced non-small cell lung cancer (NSCLC). (2006) (5)
- Dissection of the polygenic architecture of neuronal Aβ production using a large sample of individual iPSC lines derived from Alzheimer’s disease patients (2022) (4)
- Whole Brain Atrophy and Sample Size Estimate via Iterative Principal Component Analysis for Twelve-month Alzheimer's Disease Trials (2013) (4)
- Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts (2016) (4)
- Novel Patient Metastatic Pleural Effusion-Derived Xenograft Model of Renal Medullary Carcinoma Demonstrates Therapeutic Efficacy of Sunitinib (2021) (3)
- Glucose metabolism patterns: A potential index to characterize brain ageing and predict high conversion risk into cognitive impairment (2022) (3)
- Biological heterogeneity in ADNI amnestic MCI (2013) (3)
- Assessment of an e-training tool for college students to improve accuracy and reduce effort associated with reading nutrition labels (2018) (3)
- On an asymptotic distribution of dependent random variables on a 3-dimensional lattice. (2010) (3)
- Feasibility study of intra-patient sorafenib dose-escalation or re-escalation in patients with previously treated advanced solid tumors (2012) (3)
- Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease (2020) (3)
- APOE effect on Alzheimer’s biomarkers in older adults with significant memory concern (2015) (3)
- P1.04-09 Immunomodulatory Effects of Afatinib and Pembrolizumab in EGFR-Mutant NSCLC with Progression on Prior EGFR-TKI (2018) (3)
- Relationship between per capita births of Cook Inlet belugas and summer salmon runs: age‐structured population modeling (2020) (3)
- Impact of apolipoprotein varepsilon4-cerebrospinal fluid beta-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment (2011) (3)
- Efficacy of an anti-CD22 antibody-monomethyl auristatin E conjugate in a preclinical xenograft model of precursor B-cell acute lymphoblastic leukemia (2017) (3)
- A multivariate cure model for left‐censored and right‐censored data with application to colorectal cancer screening patterns (2016) (3)
- Quantitation of sentinel node metastatic burden and Her-2/neu over-expression accurately predicts residual axillary nodal involvement and extranodal disease in breast cancer. (2013) (3)
- Update on the large-scale screening of ALK fusion oncogene transcripts in archival NSCLC tumor specimens using multiplexed RT-PCR assays. (2012) (3)
- Rash severity and dose in phase I dose escalation cetuximab (C225) trial (2008) (3)
- Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology (2020) (3)
- Pharmacodynamic separation (PDS) of pemetrexed (Pem) and erlotinib (Erl) in patients (pts) with advanced, EGFR wild-type (wt) Non-Small Cell Lung Cancer (NSCLC): A randomized phase II trial. (2015) (2)
- P3-040: Alzheimer's disease neuroimaging initiative: Baseline characteristics (2008) (2)
- Subtypes based on CSF and MRI markers in normal elderly predict cognitive decline (2010) (2)
- 318 Anti-inflammatory drug use and risk of incident Alzheimer's disease in a defined community population (1996) (2)
- Review of Existing Models to Predict Reductions in Neural Tube Defects Due to Folic Acid Fortification and Model Results Using Data from Cameroon (2021) (2)
- Dual epidermal growth factor receptor (EGFR) inhibition: Phase I study combining cetuximab (C225) and erlotinib (E) in advanced solid tumors. (2016) (2)
- CLUSTERING ALZHEIMER'S PATIENTS INTO “SYNDROME GROUPS” USING LONGITUDINAL BIOMARKER AND COGNITIVE TRAJECTORIES (2016) (2)
- Combination checkpoint immunotherapy and cytotoxic chemotherapy: Further results from a phase Ib/II trial of pembrolizumab and docetaxel or gemcitabine in patients with advanced or metastatic urothelial cancer. (2018) (2)
- O1-04-04 The Alzheimer’s disease neuroimaging initiative: Progress report (2007) (2)
- Estimating prevalence and incidence of chronic conditions in the elderly: design and sampling issues. (1994) (2)
- The Communication Gap Between the Medical System and Community Resources for Dementia-Related Behavioral Symptom Management: Family Caregiver Perspectives. (2018) (2)
- Impact of an Interactive On-line Tool on Therapeutic Decision-Making for Patients with Advanced Non–Small-Cell Lung Cancer (2015) (2)
- Sources of variability in medical student evaluations on the internal medicine clinical rotation (2012) (2)
- A novel gamma GLM approach to MRI relaxometry comparisons (2020) (2)
- MORE POWERFUL STATISTICAL APPROACHES FOR LONGITUDINAL COMPARISONS OF AD SUBTYPES ON CSF AND IMAGING BIOMARKERS FROM DOMINANTLY INHERITED ALZHEIMER NETWORK (DIAN) AND ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE (ADNI) (2018) (2)
- Injection-site Reactions to Sustained-release Meloxicam in Sprague-Dawley Rats. (2020) (2)
- Discussion of joint modeling longitudinal and survival data (2004) (2)
- Residential Proximity to Naturally Occurring Asbestos and Mesothelioma Risks: Further Consideration of Exposure Misclassification and Occupational Confounding (2006) (2)
- Armed and prohibited: characteristics of unlawful owners of legally purchased firearms (2020) (1)
- Everolimus plus bicalutamide in men with castration-resistant prostate cancer (CRPC): Final results of a phase II trial. (2014) (1)
- Comments on “Causal versus spurious spatial exposure-response associations in health risk analysis” and “A cautionary tale: The characteristics of two-dimensional distributions and their effects on epidemiological studies employing an ecological design” (2013) (1)
- Predictive value of EGFR and KRAS mutations detected in plasma from non-small cell lung cancer (NSCLC) patients treated with docetaxel and intermittent erlotinib (2008) (1)
- Escalating weekly doses of cetuximab: A phase I trial in advanced solid tumors. (2006) (1)
- Pentoxifylline trental decreases tumor necrosis factor tnf and hiv replication in patients with aids (1992) (1)
- Novel nanomolecular HLA-DR10 antibody mimics provide a potent system for molecular therapy and imaging (2008) (1)
- Asian American Network for Cancer Awareness, Research, and Training (AANCART): Fifth Asian American Cancer Control Academy (2005) (1)
- Multivariate Longitudinal Modeling of Changes Over Time in Two Cardiovascular Risk Factors from Childhood into Young Adulthood (2001) (1)
- Sample Surveys in the Health Sciences (2005) (1)
- Proteasome inhibition with bortezomib (BORT) in combination with topotecan : A phase I solid tumor trial (2007) (1)
- Phase I/II trial of combination nab-paclitaxel and pemetrexed in advanced solid tumor patients (pts) with emphasis on non-small cell lung cancer (NSCLC). (2013) (1)
- Author Correction: Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease (2021) (1)
- Tumor Grade Predicts Tumor Proportion in Fresh Frozen Tissue Samples for Breast Cancer Research (2008) (1)
- Correction: Misunderstanding of Front-Of-Package Nutrition Information on US Food Products (2015) (1)
- THE DOMINANTLY INHERITED ALZHEIMER NETWORK (DIAN)-ALZHEIMER’S DISEASE NEUROIMAGING INITIATIVE (ADNI) COMPARISON STUDY: CHALLENGES AND OPPORTUNITIES (2018) (1)
- Correction: Attenuated Age-Impact on Systemic Inflammatory Markers in the Presence of a Metabolic Burden (2015) (1)
- INDEX OF PAIRED HELICAL FILAMENT PATHOLOGY IN THE TEMPORALLOBE; RELATION TO BRAAK STAGE AND COGNTITVE FUNCTION IN THE RELIGIOUS STUDY (1997) (1)
- Incident Antipsychotic Use in a Diverse Population with Dementia (2016) (1)
- Relation of early-life cognitive activity to late-life cognitive function (2000) (1)
- Injection Reactions after Administration of Sustained-release Meloxicam to BALB/cJ, C57BL/6J, and Crl:CD1(ICR) Mice. (2021) (1)
- Phase II trial of bevacizumab (B) and ixabepilone (Ix) for advanced non-squamous NSCLC progressive after first-line therapy. (2012) (1)
- Heritability of regional brain volumes in large-scale neuroimaging and genetic studies (2017) (1)
- Type-2 dominant cytokine gene expression following hepatic surgery. (2006) (1)
- Psychosocial outcomes and care utilization among rural and nonrural cancer patients. (2019) (1)
- Special features of Lumbar Spinal Canal Stenosis (2021) (0)
- Alzheimer’s-related brain damage shows sex-specific links with risk factors (2022) (0)
- Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer’s Dementia (2018) (0)
- Author Correction: Multimodal hippocampal subfield grading for Alzheimer’s disease classification (2020) (0)
- Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer’s Disease via Fusion of Clinical, Imaging and Omic Features (2017) (0)
- Phase I trial of combination nab-paclitaxel and pemetrexed in advanced solid tumors (2008) (0)
- Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease (2020) (0)
- NEUROPATHOLOGICAL DIFFERENCES ACROSS THREE ETHNORACIAL GROUPS WITH DEMENTIA (2018) (0)
- Prospective evaluation of low-dose ketoconazole plus hydrocortisone (HC) in chemotherapy-pretreated castration-resistant prostate cancer (CRPC) patients. (2014) (0)
- Understanding Asian American awareness of and experience with cancer clinical trials (CCTs): A mixed methods approach (2005) (0)
- P2-254 Imaging biomarkers to monitor treatment effects for Alzheimer’s disease trials: The Alzheimer’s disease imaging initiative (2006) (0)
- Abstract 3720: Encouraging activity of bicalutamide and everolimus in castration-resistant prostate cancer (CRPC): Early results from a phase I/II clinical trial (2010) (0)
- Skin dose effects of postmastectomy chest wall radiation therapy using brass mesh as an alternative to a bolus. (2012) (0)
- Biomarkers and imaging in Alzheimer's disease: a partnership between biotechnology and clinical medicine (第26回 バイオテクノロジー シンポジウム 予稿集) -- (Oral session) (2008) (0)
- Abstract 3165: Influence Of Hypertension On Cognition Is Mediated By Brain Injury (2012) (0)
- A blood-based signature of cerebrospinal fluid Aβ1–42 status (2019) (0)
- Differential Response Rates In Vivo to Irradiation among Patients with Human Papillomavirus Positive and Negative Oropharyngeal Cancer (2011) (0)
- Cholinergic and neurotrophic markers within the nucleus basalis in elderly individuals with mild cognitive impairment and early Alzheimer's disease (2000) (0)
- Cognitive, neuropsychiatric and imaging comparisons between early‐onset and late‐onset Alzheimer’s disease participants from LEADS and ADNI3 (2021) (0)
- 151. Scoliosis Surgery in Duchennes Muscular Dystrophy, Peri-Operative Medical and Surgical Considerations (2009) (0)
- Author Correction: FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease (2022) (0)
- Apolipoprotein E ɛ4–related effects on cognition are limited to the Alzheimer’s disease spectrum (2021) (0)
- Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics (2019) (0)
- Response to Zywieck and Kirkby paper (2018) (0)
- Abstract 336: Genomic annotation of non-small cell lung cancer patient-derived xenograft models for personalized cancer therapy. (2013) (0)
- Stroke prevention (2019) (0)
- Aging in Fragile X Premutation Carriers (2016) (0)
- COMPARING BIOMARKER RATES OF CHANGE IN AUTOSOMAL DOMINANT VERSUS SPORADIC ALZHEIMER DISEASE (2018) (0)
- Brain multiplexes reveal morphological connectional biomarkers fingerprinting late brain dementia states (2018) (0)
- Impact of a mass media campaign (MMC) on awareness of and willingness to participate in cancer clinical trials (CCT): Results from 2,269 survey respondents. (2006) (0)
- Effect of radiotherapy and chemotherapy on the survival rate of Asian Americans with nasopharyngeal carcinoma (2022) (0)
- Domain-specific rates of cognitive change in MCI (2009) (0)
- Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration (2020) (0)
- The Polygenic Risk Score Knowledge Base offers a centralized online repository for calculating and contextualizing polygenic risk scores (2021) (0)
- GenEpi: gene-based epistasis discovery using machine learning (2020) (0)
- Mixture models for sequences of events in Alzheimer's disease progression (2013) (0)
- The trend of disruption in the functional brain network topology of Alzheimer’s disease (2021) (0)
- The path to regulatory qualification of low baseline hippocampal volume as a prognostic biomarker in clinical trials of patients with early Alzheimer’s disease: For the coalition against major diseases (2015) (0)
- Phase II trial of dose-escalated sorafenib in advanced solid tumors. (2010) (0)
- 380 Projected incidence of Alzheimer's disease in the United States (1996) (0)
- Value added by MRI for predicting clinical conversion to dementia in a heterogeneous community cohort (2010) (0)
- Use of Iterative Principal Component Analysis Based Whole Brain Atrophy to Detect Twelve-month Change in Alzheimer's Disease in Multi-center Trials: Findings from the Alzheimer's Disease Neuroimaging Initiative (2013) (0)
- Weight Loss in Persons with Alzheimer's Disease: A Prospective Analysis (1997) (0)
- Deep learning-based polygenic risk analysis for Alzheimer’s disease prediction (2023) (0)
- Overcoming barriers to accrual: An assessment of 1,187 cancer patients’ (Pts) and caregivers’ awareness of and willingness to participate in cancer clinical trials (CCTs) (2005) (0)
- Apolipoprotein E ɛ4–related effects on cognition are limited to the Alzheimer’s disease spectrum (2021) (0)
- The path to regulatory qualification of cerebrospinal fluid biomarkers as enrichment tools in clinical trials of patients with early Alzheimer’s disease: For the coalition against major diseases (2015) (0)
- THE USE OF CONVOLUTIONAL NEURAL NETWORKS TO QUANTIFY AMYLOID PLAQUES IN POSTMORTEM HUMAN BRAIN (2018) (0)
- Effect of dementia diagnosis on receipt of postoperative colon cancer chemotherapy. (2015) (0)
- Characteristic patterns of inter- and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer’s disease (2018) (0)
- 1078: Use of a Yeast Functional Assay to Determine the Frequency of P53 Alterations in Localized Prostate Cancer (2004) (0)
- Awareness among oncology providers and financial counselors of a California law requiring third-party payer coverage of cancer clinical Trial (CCT) Costs (2005) (0)
- Prospective Evaluation of Cardiac Toxicity After Stereotactic Body Radiation Therapy for Thoracic Tumors Using Echocardiographic Findings (2012) (0)
- Pattern Discovery in Brain Imaging Genetics via SCCA Modeling with a Generic Non-convex Penalty (2017) (0)
- Value added by MRI for predicting clinical conversion to dementia in a heterogeneous community cohort (2010) (0)
- Pharmacodynamic separation (PDS) of gemcitabine (Gem) and the epidermal growth factor receptor (EGFR) inhibitor erlotinib (E) in patients (Pts) with advanced pancreatic cancer: Phase II results. (2013) (0)
- IC-P-104 Imaging biomarkers to monitor treatment effects for Alzheimer’s disease trials: The Alzheimer’s disease imaging initiative (2006) (0)
- Erratum: Outcomes of comprehensive heart care programs in high-risk women (Journal of Women's Health (2010) 19:1) (2010) (0)
- Beta amyloid, tau, neuroimaging, and cognition: sequence modeling of biomarkers for Alzheimer’s Disease (2012) (0)
- 381 The Chicago health and aging project (CHAP): Study design and methods (1996) (0)
- 182: Her-2/neu over-expression and proportional extent of sentinel node metastatic burden are predictive of extensive residual axillary nodal involvement in breast cancer (2007) (0)
- Prediction of disease progression in mild cognitive impairment from vMRI and concordance with cerebrospinal fluid biomarkers (2012) (0)
- Contents Vol. 27, 2009 (2009) (0)
- Anatomical Contouring Guidelines and Dosimetric Analysis of Brachial Plexus Segments for Patients Treated by Intensity-Modulated Radiotherapy for Head and Neck Cancer (2012) (0)
- Mo1462 Colostomy vs. Ileostomy - an ACS-NSQIP Evaluation of Complications From Diverting Stoma Reversal (2012) (0)
- Subject Index Vol. 27, 2009 (2009) (0)
- Review Articles The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans (2010) (0)
- Author Correction: Multimodal hippocampal subfield grading for Alzheimer’s disease classification (2020) (0)
- ImpactoftheAlzheimer'sDiseaseNeuroimagingInitiative,2004to2014 (2015) (0)
- A Multivariate Cure Model for Left- and Right-Censored Data with Application to Colorectal Cancer Screening Patterns (2015) (0)
- Randomized Phase 2 Trial of Pharmacodynamic Separation of Pemetrexed and Intercalated Erlotinib Versus Pemetrexed Alone for Advanced Nonsquamous, Non e small-cell Lung Cancer (2017) (0)
- Abstract 2703: Effect of route and dosing regimen on efficacy of SH7139 in mouse Burkitt's lymphoma xenografts (2014) (0)
- Nigral degeneration and the clinical expression of Alzheimers disease (1998) (0)
- A distinct subpopulation of leukemia initiating cells in acute precursor B lymphoblastic leukemia: quiescent phenotype and unique transcriptomic profile (2022) (0)
- Title Large-scale genomics unveil polygenic architecture of human cortical surface area Permalink (2015) (0)
- Prediction of disease progression in mild cognitive impairment from vMRI and concordance with CSF biomarkers (2012) (0)
- P4‐035: WITHDRAWN (2018) (0)
- MODELING LONG-TERM DISEASE PROGRESSION WITH COVARIATES (2014) (0)
- P4‐036: WITHDRAWN (2018) (0)
This paper list is powered by the following services:
Other Resources About Laurel Beckett
What Schools Are Affiliated With Laurel Beckett?
Laurel Beckett is affiliated with the following schools:
